NO822263L - Fremgangsmaate for fremstilling av fenetyl-tiazolderivater - Google Patents
Fremgangsmaate for fremstilling av fenetyl-tiazolderivaterInfo
- Publication number
- NO822263L NO822263L NO822263A NO822263A NO822263L NO 822263 L NO822263 L NO 822263L NO 822263 A NO822263 A NO 822263A NO 822263 A NO822263 A NO 822263A NO 822263 L NO822263 L NO 822263L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- phenyl
- preparation
- derivatives
- ether
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- -1 methylenedioxy Chemical group 0.000 claims abstract description 4
- 125000001424 substituent group Chemical group 0.000 claims abstract description 4
- 125000005843 halogen group Chemical group 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- PDQAZBWRQCGBEV-UHFFFAOYSA-N Ethylenethiourea Chemical compound S=C1NCCN1 PDQAZBWRQCGBEV-UHFFFAOYSA-N 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- NVHNGVXBCWYLFA-UHFFFAOYSA-N 1,3-diazinane-2-thione Chemical compound S=C1NCCCN1 NVHNGVXBCWYLFA-UHFFFAOYSA-N 0.000 claims description 2
- KEWBUOMVBFMGNS-UHFFFAOYSA-N 2-(2-phenylethyl)-1,3-thiazole Chemical class N=1C=CSC=1CCC1=CC=CC=C1 KEWBUOMVBFMGNS-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract description 2
- 208000020401 Depressive disease Diseases 0.000 abstract description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 206010015995 Eyelid ptosis Diseases 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000007912 intraperitoneal administration Methods 0.000 description 3
- 201000003004 ptosis Diseases 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 2
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 2
- 229960003147 reserpine Drugs 0.000 description 2
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- IQFINGGEJYDSFN-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine-2-thiol Chemical compound SC1NCC=CN1 IQFINGGEJYDSFN-UHFFFAOYSA-N 0.000 description 1
- MLPAIIATLGUTEE-UHFFFAOYSA-N 1,3-thiazol-5-ol Chemical compound OC1=CN=CS1 MLPAIIATLGUTEE-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- KKYVAASKEREZBA-UHFFFAOYSA-N 3,5-dibromo-1,7-bis(3-chlorophenyl)-1,7-diphenylheptan-4-one Chemical compound BrC(CC(C1=CC=CC=C1)C1=CC(=CC=C1)Cl)C(=O)C(CC(C1=CC(=CC=C1)Cl)C1=CC=CC=C1)Br KKYVAASKEREZBA-UHFFFAOYSA-N 0.000 description 1
- OPFIBBKGLJRJRP-UHFFFAOYSA-N 3-hydroxy-2h-1,3-thiazole Chemical compound ON1CSC=C1 OPFIBBKGLJRJRP-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000009519 pharmacological trial Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8113078A FR2508909A1 (fr) | 1981-07-03 | 1981-07-03 | Derives phenethyles de thiazole, leur preparation et leur application en therapeuthique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO822263L true NO822263L (no) | 1983-01-04 |
Family
ID=9260145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822263A NO822263L (no) | 1981-07-03 | 1982-06-30 | Fremgangsmaate for fremstilling av fenetyl-tiazolderivater |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4431648A (el) |
| EP (1) | EP0069623B1 (el) |
| JP (1) | JPS5815984A (el) |
| AT (1) | ATE12645T1 (el) |
| AU (1) | AU550191B2 (el) |
| CA (1) | CA1196638A (el) |
| DE (1) | DE3262971D1 (el) |
| DK (1) | DK298382A (el) |
| ES (1) | ES513671A0 (el) |
| FI (1) | FI71939C (el) |
| FR (1) | FR2508909A1 (el) |
| GR (1) | GR76211B (el) |
| HU (1) | HU186086B (el) |
| IE (1) | IE53302B1 (el) |
| IL (1) | IL66208A (el) |
| NO (1) | NO822263L (el) |
| NZ (1) | NZ201143A (el) |
| PT (1) | PT75181A (el) |
| ZA (1) | ZA824755B (el) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3806515A (en) * | 1968-07-31 | 1974-04-23 | W Houlihan | Certain 2-alkyl-3-phenyl-5,6-dihydroimidazo(2,1-b)thiazoles |
| CH513918A (de) * | 1968-07-31 | 1971-10-15 | Sandoz Ag | Verfahren zur Herstellung von 2-n-Alkyl-3-phenyl-6,7-dihydro-5H-thiazolo(3,2-a)pyrimidinen bzw. 2-n-Alkyl-3-phenyl-5,6-dihydroimidazo(2,1-b)thiazolen |
| FR2479831A1 (fr) * | 1980-04-08 | 1981-10-09 | Synthelabo | Derives de thiazole, leur preparation et leur application en therapeutique |
-
1981
- 1981-07-03 FR FR8113078A patent/FR2508909A1/fr active Granted
-
1982
- 1982-06-21 DE DE8282401126T patent/DE3262971D1/de not_active Expired
- 1982-06-21 AT AT82401126T patent/ATE12645T1/de not_active IP Right Cessation
- 1982-06-21 EP EP82401126A patent/EP0069623B1/fr not_active Expired
- 1982-06-30 NO NO822263A patent/NO822263L/no unknown
- 1982-07-02 JP JP57116085A patent/JPS5815984A/ja active Pending
- 1982-07-02 PT PT75181A patent/PT75181A/pt unknown
- 1982-07-02 DK DK298382A patent/DK298382A/da not_active Application Discontinuation
- 1982-07-02 GR GR68632A patent/GR76211B/el unknown
- 1982-07-02 AU AU85562/82A patent/AU550191B2/en not_active Ceased
- 1982-07-02 CA CA000406523A patent/CA1196638A/en not_active Expired
- 1982-07-02 FI FI822365A patent/FI71939C/fi not_active IP Right Cessation
- 1982-07-02 IL IL66208A patent/IL66208A/xx unknown
- 1982-07-02 NZ NZ201143A patent/NZ201143A/xx unknown
- 1982-07-02 ES ES513671A patent/ES513671A0/es active Granted
- 1982-07-02 IE IE1616/82A patent/IE53302B1/en unknown
- 1982-07-02 ZA ZA824755A patent/ZA824755B/xx unknown
- 1982-07-02 HU HU822184A patent/HU186086B/hu unknown
- 1982-07-02 US US06/394,881 patent/US4431648A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5815984A (ja) | 1983-01-29 |
| FI71939C (fi) | 1987-03-09 |
| ZA824755B (en) | 1983-04-27 |
| FI822365L (fi) | 1983-01-04 |
| GR76211B (el) | 1984-08-04 |
| FI71939B (fi) | 1986-11-28 |
| CA1196638A (en) | 1985-11-12 |
| IE821616L (en) | 1983-01-03 |
| IL66208A0 (en) | 1982-11-30 |
| ATE12645T1 (de) | 1985-04-15 |
| FR2508909B1 (el) | 1983-12-23 |
| AU550191B2 (en) | 1986-03-06 |
| HU186086B (en) | 1985-05-28 |
| FI822365A0 (fi) | 1982-07-02 |
| PT75181A (fr) | 1982-08-01 |
| US4431648A (en) | 1984-02-14 |
| IL66208A (en) | 1984-11-30 |
| EP0069623A1 (fr) | 1983-01-12 |
| DE3262971D1 (en) | 1985-05-15 |
| AU8556282A (en) | 1983-01-06 |
| DK298382A (da) | 1983-01-04 |
| ES8304998A1 (es) | 1983-03-16 |
| NZ201143A (en) | 1983-09-30 |
| EP0069623B1 (fr) | 1985-04-10 |
| IE53302B1 (en) | 1988-10-12 |
| FR2508909A1 (fr) | 1983-01-07 |
| ES513671A0 (es) | 1983-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI84062B (fi) | Foerfarande foer framstaellning av nya, terapeutiskt aktiva pyridin-2-etrar och pyridin-2-tioetrar. | |
| DK142498B (da) | Analogifremgangsmåde til fremstilling af benzopyridoazepinderivater. | |
| NO178029B (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrazolopyrimidinoner | |
| NZ213130A (en) | Bicyclic compounds with two common nitrogen atoms; pharmaceutical composition | |
| JPS6150979A (ja) | ピリジン誘導体およびその製造法 | |
| IE41457B1 (en) | Thienothiazine derivatives | |
| SU635874A3 (ru) | Способ получени производных 1,5,10, 10а-тетрагидротиазоло /3,4-в/изохинолина или их оптических изомеров или кислотно-аддитивных солей | |
| NO840557L (no) | Kinolonkarboksylsyrer, fremgangsmaate til deres fremstilling samt antibakterielle midler som inneholder disse | |
| SK89693A3 (en) | New 4,5-dihydro-4-oxopyrolo[1,2-a]-quinoxalines and responsive azaanalogues and method of their preparation | |
| DK154137B (da) | Analogifremgangsmaade til fremstilling af meta-sulfonamido-benzamidderivater | |
| NO172392B (no) | Analogifremgangsmaate for fremstilling av 1h,3h-(1,2-c)-pyrrolo-7-tiazolkarboksamider | |
| JPH0256358B2 (el) | ||
| KR20090110368A (ko) | Ｇｌｙｔ-1 억제제의 합성 방법 | |
| NO822263L (no) | Fremgangsmaate for fremstilling av fenetyl-tiazolderivater | |
| NO783239L (no) | Nye 7-azabenzimidazoler med basiske sidekjeder | |
| JP2000026418A (ja) | ４―フェニル―１，２，３，６―テトラヒドロピリジンの誘導体の新規の製造方法及び用いられる中間体 | |
| NO166227B (no) | Analogifremgangsmaate for fremstilling av nye antibakterielle pyrido-benzoksazin-6-karboksylsyrer. | |
| SU1729293A3 (ru) | Способ получени производных 5-галоидтиеноизотиазол-3(2Н)-он-1,1-диоксидов | |
| KR20020052213A (ko) | 6-메틸-2-(4-메틸-페닐)-이미다조[1,2-ａ]피리미딘-3-(Ｎ,Ｎ-디메틸-아세트아미드) 및 중간체의 제조 방법 | |
| US4292431A (en) | Process for the production of hydroxymethylimidazoles | |
| JPS6019317B2 (ja) | チエノチアジン誘導体及びその製造方法 | |
| US3424749A (en) | Certain n-(benzenesulfonyl) pipecolinic acids and lower alkyl esters thereof | |
| JPS61249968A (ja) | ５−ヒドラジノ−１ｈ−ピラゾ−ル系化合物 | |
| IE49383B1 (en) | Benzazepine derivatives | |
| NO800326L (no) | Fremgangsmaate for fremstilling av tiazolderivater |